Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) EPS (Basic) (2021 - 2025)

PAVmed has reported EPS (Basic) over the past 5 years, most recently at -$5.52 for Q4 2025.

  • Quarterly results put EPS (Basic) at -$5.52 for Q4 2025, down 105.76% from a year ago — trailing twelve months through Dec 2025 was -$5.27 (down 105.85% YoY), and the annual figure for FY2025 was -$5.63, down 105.68%.
  • EPS (Basic) for Q4 2025 was -$5.52 at PAVmed, down from -$0.29 in the prior quarter.
  • Over the last five years, EPS (Basic) for PAVM hit a ceiling of $95.85 in Q4 2024 and a floor of -$14.25 in Q4 2022.
  • Median EPS (Basic) over the past 5 years was -$0.29 (2022), compared with a mean of $3.26.
  • Biggest five-year swings in EPS (Basic): plummeted 5837.5% in 2022 and later skyrocketed 5066.32% in 2024.
  • PAVmed's EPS (Basic) stood at -$0.24 in 2021, then plummeted by 5837.5% to -$14.25 in 2022, then soared by 86.46% to -$1.93 in 2023, then skyrocketed by 5066.32% to $95.85 in 2024, then crashed by 105.76% to -$5.52 in 2025.
  • The last three reported values for EPS (Basic) were -$5.52 (Q4 2025), -$0.29 (Q3 2025), and -$0.74 (Q2 2025) per Business Quant data.